Adams VR - Search Results

1

Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings.

Harvey RD, Adams VR, Beardslee T, Medina P. Harvey RD, et al. Among authors: adams vr. J Oncol Pharm Pract. 2020 Sep;26(6):1461-1474. doi: 10.1177/1078155220931926. Epub 2020 Jun 20. J Oncol Pharm Pract. 2020. PMID: 32567494 Free PMC article. Review.

2

Histological and genetic markers for non-small-cell lung cancer: customizing treatment based on individual tumor biology.

Adams VR, Harvey RD. Adams VR, et al. Am J Health Syst Pharm. 2010 Jan 1;67(1 Suppl 1):S3-9, quiz S15-6. doi: 10.2146/ajhp090456. Am J Health Syst Pharm. 2010. PMID: 20044377

3

PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses.

Medina PJ, Adams VR. Medina PJ, et al. Among authors: adams vr. Pharmacotherapy. 2016 Mar;36(3):317-34. doi: 10.1002/phar.1714. Pharmacotherapy. 2016. PMID: 26822752 Free PMC article. Review.

4

Association of hypertension and treatment outcomes in advanced stage non-small cell lung cancer patients treated with bevacizumab or non-bevacizumab containing regimens.

Yan LZ, Dressler EV, Adams VR. Yan LZ, et al. Among authors: adams vr. J Oncol Pharm Pract. 2018 Apr;24(3):209-217. doi: 10.1177/1078155217690921. Epub 2017 Feb 21. J Oncol Pharm Pract. 2018. PMID: 29284349

5

Alternate dosage formulations of oral targeted anticancer agents.

Wagner C, Adams V, Overley C. Wagner C, et al. J Oncol Pharm Pract. 2021 Dec;27(8):1963-1981. doi: 10.1177/10781552211037976. Epub 2021 Sep 24. J Oncol Pharm Pract. 2021. PMID: 34558356 Review.

6

Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects.

Bence AK, Anderson EB, Halepota MA, Doukas MA, DeSimone PA, Davis GA, Smith DA, Koch KM, Stead AG, Mangum S, Bowen CJ, Spector NL, Hsieh S, Adams VR. Bence AK, et al. Among authors: adams vr. Invest New Drugs. 2005 Jan;23(1):39-49. doi: 10.1023/B:DRUG.0000047104.45929.ea. Invest New Drugs. 2005. PMID: 15528979 Clinical Trial.

7

An important recent development in cancer research has been the identification of new genetic and molecular tumor profiling techniques. Introduction.

Adams VR, Sheth S. Adams VR, et al. Am J Health Syst Pharm. 2010 Jan 1;67(1 Suppl 1):S1-2. doi: 10.2146/ajhp090455. Am J Health Syst Pharm. 2010. PMID: 20044375 No abstract available.

8

Capecitabine-induced ventricular fibrillation arrest: Possible Kounis syndrome.

Kido K, Adams VR, Morehead RS, Flannery AH. Kido K, et al. Among authors: adams vr. J Oncol Pharm Pract. 2016 Apr;22(2):335-40. doi: 10.1177/1078155214563814. Epub 2015 Apr 13. J Oncol Pharm Pract. 2016. PMID: 25870182

9

Association of time to antibiotics and clinical outcomes in adult hematologic malignancy patients with febrile neutropenia.

Butts AR, Bachmeier CC, Dressler EV, Liu M, Cowden A, Talbert J, Adams VR. Butts AR, et al. Among authors: adams vr. J Oncol Pharm Pract. 2017 Jun;23(4):278-283. doi: 10.1177/1078155216687150. Epub 2017 Jan 11. J Oncol Pharm Pract. 2017. PMID: 28077045

10

Multiple sclerosis outcomes after cancer immunotherapy.

Garcia CR, Jayswal R, Adams V, Anthony LB, Villano JL. Garcia CR, et al. Clin Transl Oncol. 2019 Oct;21(10):1336-1342. doi: 10.1007/s12094-019-02060-8. Epub 2019 Feb 20. Clin Transl Oncol. 2019. PMID: 30788836 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters